198 related articles for article (PubMed ID: 32772733)
1. Serum Perfluoroalkyl Substances, Vaccine Responses, and Morbidity in a Cohort of Guinea-Bissau Children.
Timmermann CAG; Jensen KJ; Nielsen F; Budtz-Jørgensen E; van der Klis F; Benn CS; Grandjean P; Fisker AB
Environ Health Perspect; 2020 Aug; 128(8):87002. PubMed ID: 32772733
[TBL] [Abstract][Full Text] [Related]
2. Predictors of serum- per- and polyfluoroalkyl substance (PFAS) concentrations among infants in Guinea-Bissau, West Africa.
Sørensen MM; Fisker AB; Dalgård C; Jensen KJ; Nielsen F; Benn CS; Grandjean P; Timmermann A
Environ Res; 2023 Jul; 228():115784. PubMed ID: 37011795
[TBL] [Abstract][Full Text] [Related]
3. Prenatal Exposure to Poly- and Perfluoroalkyl Substances (2009-2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort.
Zell-Baran LM; Dabelea D; Norris JM; Glueck DH; Adgate JL; Brown JM; Harrall KK; Calafat AM; Starling AP
Environ Health Perspect; 2023 Dec; 131(12):127018. PubMed ID: 38147368
[TBL] [Abstract][Full Text] [Related]
4. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination.
Timmermann CA; Budtz-Jørgensen E; Jensen TK; Osuna CE; Petersen MS; Steuerwald U; Nielsen F; Poulsen LK; Weihe P; Grandjean P
J Immunotoxicol; 2017 Dec; 14(1):39-49. PubMed ID: 28091126
[TBL] [Abstract][Full Text] [Related]
5. High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden.
Andersson AG; Lundgren A; Xu Y; Nielsen C; Lindh CH; Pineda D; Cederlund J; Pataridou E; Søgaard Tøttenborg S; Ugelvig Petersen K; Fletcher T; Lagging M; Bemark M; Jakobsson K; Li Y
Environ Health Perspect; 2023 Aug; 131(8):87007. PubMed ID: 37578904
[TBL] [Abstract][Full Text] [Related]
6. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
[TBL] [Abstract][Full Text] [Related]
8. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Timmermann A; Budtz-Jørgensen E
J Immunotoxicol; 2017 Dec; 14(1):188-195. PubMed ID: 28805477
[TBL] [Abstract][Full Text] [Related]
9. Child mortality following standard, medium or high titre measles immunization in West Africa.
Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
[TBL] [Abstract][Full Text] [Related]
10. Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults.
Stein CR; Ge Y; Wolff MS; Ye X; Calafat AM; Kraus T; Moran TM
Environ Res; 2016 Aug; 149():171-178. PubMed ID: 27208468
[TBL] [Abstract][Full Text] [Related]
11. Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Budtz-Jørgensen E
Environ Health Perspect; 2017 Jul; 125(7):077018. PubMed ID: 28749778
[TBL] [Abstract][Full Text] [Related]
12. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense Child Cohort.
Dalsager L; Christensen N; Husby S; Kyhl H; Nielsen F; Høst A; Grandjean P; Jensen TK
Environ Int; 2016 Nov; 96():58-64. PubMed ID: 27608427
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey.
Stein CR; McGovern KJ; Pajak AM; Maglione PJ; Wolff MS
Pediatr Res; 2016 Feb; 79(2):348-57. PubMed ID: 26492286
[TBL] [Abstract][Full Text] [Related]
14. Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau.
Varma A; Jensen AKG; Thysen SM; Pedersen LM; Aaby P; Fisker AB
BMC Public Health; 2019 Nov; 19(1):1506. PubMed ID: 31711464
[TBL] [Abstract][Full Text] [Related]
15. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
[TBL] [Abstract][Full Text] [Related]
16. Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.
Byberg S; Fisker AB; Rodrigues A; Balde I; Enemark U; Aaby P; Benn CS; Griffiths UK
Trop Med Int Health; 2017 Jan; 22(1):12-20. PubMed ID: 27717100
[TBL] [Abstract][Full Text] [Related]
17. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study.
Garly ML; Jensen H; Martins CL; Balé C; Baldé MA; Lisse IM; Aaby P
Pediatr Infect Dis J; 2004 Dec; 23(12):1086-92. PubMed ID: 15626943
[TBL] [Abstract][Full Text] [Related]
19. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
[TBL] [Abstract][Full Text] [Related]
20. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
